Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine
- PMID: 28834955
- PMCID: PMC5807132
- DOI: 10.1097/INF.0000000000001749
Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine
Abstract
Background: HIV-1 infection may impair transplacental antibody transfer to infants. The impact of highly active antiretroviral treatment (ART) given during pregnancy on transplacental antibody transport is unknown.
Methods: HIV-1 infected pregnant women with CD4 counts between 200 - 500 were randomized to short-course zidovudine (ZDV) or triple ART at 32 weeks gestation for prevention of mother-to-child HIV-1 transmission. Levels of maternal antibody against measles, pneumococcus and rotavirus at delivery, and antibody transfer to the baby through cord blood, were compared between trial arms.
Results: Overall, 141 and 148 women were randomized to triple ART and ZDV, respectively; cord blood was available for a subset (n = 20 in triple ART and n = 22 in ZDV). Maternal antibody levels to all pathogens during pregnancy and at delivery were not significantly different between arms. Within each arm, antibody levels at delivery were lower than at enrolment. For all antibodies, a woman's levels before delivery were an important predictor of amount transferred to her infant. Women on triple ART transferred higher levels of pathogen-specific antibodies when compared with women on short course ZDV.
Conclusions: Women on triple ART transferred higher levels of pathogen-specific antibodies compared with women on ZDV alone.
Similar articles
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.Antivir Ther. 2008;13(6):799-807. Antivir Ther. 2008. PMID: 18839781 Free PMC article. Clinical Trial.
-
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Lancet Infect Dis. 2011. PMID: 21237718 Clinical Trial.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. doi: 10.1002/14651858.CD003510.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3 PMID: 17253490 Updated. Review.
Cited by
-
Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique.Front Immunol. 2021 Mar 3;12:614246. doi: 10.3389/fimmu.2021.614246. eCollection 2021. Front Immunol. 2021. PMID: 33746958 Free PMC article.
-
Expression profiles of miR3181 and miR199a in plasma and placenta of virally suppressed HIV-1 infected Cameroonian pregnant women at delivery.PLoS One. 2022 May 20;17(5):e0268820. doi: 10.1371/journal.pone.0268820. eCollection 2022. PLoS One. 2022. PMID: 35594307 Free PMC article.
-
Breast Milk Virome and Bacterial Microbiome Resilience in Kenyan Women Living with HIV.mSystems. 2021 Mar 16;6(2):e01079-20. doi: 10.1128/mSystems.01079-20. mSystems. 2021. PMID: 33727396 Free PMC article.
-
Reduced Transplacental Transfer of Antimalarial Antibodies in Kenyan HIV-Exposed Uninfected Infants.Open Forum Infect Dis. 2019 May 20;6(6):ofz237. doi: 10.1093/ofid/ofz237. eCollection 2019 Jun. Open Forum Infect Dis. 2019. PMID: 31214627 Free PMC article.
-
Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.Vaccine. 2022 Jul 30;40(32):4361-4370. doi: 10.1016/j.vaccine.2022.06.034. Epub 2022 Jun 17. Vaccine. 2022. PMID: 35725783 Free PMC article. Review.
References
-
- Nakiyingi JS, Bracher M, Whitworth JA, Ruberantwari A, Busingye J, Mbulaiteye SM, et al. Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS. 2003;17(12):1827–1834. - PubMed
-
- Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26(6):519–526. - PubMed
-
- Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, et al. Infant Morbidity, Mortality, and Breast Milk Immunologic Profiles among Breast-Feeding HIV-Infected and HIV-Uninfected Women in Botswana. J Infect Dis. 2007;196(4):562–569. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials